Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...

A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...

After more than a decade of digital transformation, pharmaceutical marketing is on the cusp of achieving what the industry ...

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

What Happened: MD's decision to sell 11,659 shares of Collegium Pharmaceutical was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total value of the sale ...

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...

We do not support the formation, amendment, or implementation of any committee that excludes industry entrepreneurs. With the upcoming LDC graduation in mind, the right decisions must be taken to ...

Our editorial team dives into the pharma industry's reaction to US tariffs on imports from the European Union and major trends from Q2 earnings calls.

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.